HER2 Support Group Forums - Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)

- General Cancer News (https://her2support.org/vbulletin/forumdisplay.php?f=45)

- - Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors (https://her2support.org/vbulletin/showthread.php?t=37467)

News	01-06-2009 08:20 PM

Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX ) today announced that it has acquired an option to license rights to SB1518, an orally available, potent, and selective inhibitor of Janus Kinase 2 (JAK2), and SB1578, also a JAK2 inhibitor, from S*BIO Pte Ltd based in Singapore.

More...

All times are GMT -7. The time now is 06:09 PM.